AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.5172
-0.0028 (-0.54%)
Apr 24, 2026, 4:00 PM EDT - Market closed
← View all transcripts

AGM 2025

Dec 16, 2025

Operator

Good morning. This webcast is being recorded. At this time, I would like to turn the meeting over to Dr. William Mitchell. Please go ahead, sir.

William Mitchell
Chair of the Board, AIM ImmunoTech

Hello, ladies and gentlemen. I would like to welcome all of you to the 2025 Annual Meeting, Stockholders of AIM ImmunoTech. I'm William Mitchell, Chair of the Board of AIM ImmunoTech. I'm serving as Chair of this meeting of stockholders. It is now shortly after 11:00 A.M. Eastern Time on December the 16th, 2025, and this meeting is officially called to order. At this time, I will turn the microphone over to Mr. Equels, who will make some introductions and take us through the agenda. Tom?

Tom Equels
CEO and President, AIM ImmunoTech

Good morning, and thank you, Dr. Mitchell. I'm Tom Equels, Chief Executive Officer and President of AIM ImmunoTech. Also present at the meeting today are Directors Nancy Bryan, David Chemerow, and Ted Kellner, and from our Senior Management Team, we have Peter Rodino, our Chief Operating Officer and General Counsel, and Robert Dickey, our Chief Financial Officer. Mr. Rodino will act as Secretary of today's meeting. We have appointed First Coast Results to act as the Independent Inspector of Elections. Mike Barbera from First Coast Results is in attendance. He has taken his oath as the Independent Inspector of Elections. The agenda and rules of conduct for this meeting are available on the web portal through which you access this meeting. To conduct an orderly meeting, we ask that all participants abide by these rules.

As stated in the rules of conduct, only stockholders of record as of the record date or their proxy holders may address the meeting. If you wish to address the meeting, please log into the virtual stockholder meeting website and type your question in the Ask a Question box for submitting a question. Appropriate questions will be addressed when the meeting has been concluded, and when the business of the meeting has been concluded, and the time for questions and answers has been announced. Thank you very much for your cooperation with these rules. As of the record date of October 24, 2025, there were 2,764,188 shares of common stock outstanding and entitled to vote at this meeting.

Based on information provided by our proxy solicitor, Sodali & Co, and subject to confirmation by the Inspector of Elections based upon the proxies we received prior to the meeting, we have sufficient votes to constitute a quorum for this meeting. Accordingly, we may lawfully conduct business. Dr. Mitchell?

William Mitchell
Chair of the Board, AIM ImmunoTech

I declare this meeting to be duly convened for the purposes of conducting such business as may properly come before it. Tom?

Tom Equels
CEO and President, AIM ImmunoTech

We have an affidavit of mailing establishing that notice of this annual meeting was duly given. A copy of the notice of meeting and the affidavit of mailing will be incorporated into the minutes of the meeting. All stockholders of record at the close of business on October 24, 2025, are entitled to vote at this annual meeting. We would now like to open the polls and attend to the business of this meeting by acting on the matters described in the notice of annual meeting that was sent with the company's definitive proxy statement to all stockholders. The board's recommendation on each of the matters to be voted on at this meeting is set forth in the company's definitive proxy statement. Bill?

William Mitchell
Chair of the Board, AIM ImmunoTech

We will now open the polls to receive those votes and allow anyone wishing to vote at this meeting the opportunity to do so. The polls are now open. The polls will close after all proposals have been presented. If you have already voted, you do not need to vote today. If you have not yet voted, or if you've previously voted but wish to change your vote, you may vote before the polls close by clicking on the vote link on the web portal through which you access this meeting. Tom?

Tom Equels
CEO and President, AIM ImmunoTech

The first proposal before the stockholders is to elect five directors. The board has nominated Nancy K. Bryan, Thomas K. Equels, William M. Mitchell, Ted D. Kellner, and David Chemerow for election as directors of the company. The second proposal is to ratify on a non-binding advisory basis the selection of BDO USA, P.C. as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The third proposal is to approve on a non-binding advisory basis the company's named executive officer compensation as disclosed in the company's definitive proxy statement. The fourth proposal is to approve on a non-binding advisory basis the frequency of an advisory vote on executive compensation. Your board recommends voting for all of the board's nominees on proposal one, four on proposal two, four on proposal three, and one year for proposal four.

Under the procedures in our bylaws, no other matters may be properly presented at this meeting, so that completes the items to be voted on at this meeting.

William Mitchell
Chair of the Board, AIM ImmunoTech

Okay. We're now going to close the polls. I'm going to pause for a few moments to allow anyone in the midst of voting to complete it before we go to close the meeting. So give me a few moments. Stockholders have been provided an opportunity to vote. I hereby declare the polls closed. I'll turn it back over to Tom.

Tom Equels
CEO and President, AIM ImmunoTech

We have been informed by the Independent Inspector of Elections that the final voting results may take several days to tabulate. We will file a current report on Form 8-K with the SEC announcing the final voting results after we receive a report from the Independent Inspector of Elections. Bill?

William Mitchell
Chair of the Board, AIM ImmunoTech

All right. Let's conclude the business portion of our meeting. Thank you for attending today's meeting. The formal business portion of this meeting is adjourned.

Tom Equels
CEO and President, AIM ImmunoTech

We will now address any appropriate questions submitted through the virtual meeting platform. I will read any appropriate questions that have been submitted, then I will provide a response on behalf of the company. There being no questions, thank you very much. That concludes our time allotted for questions, and we will now close the meeting. Again, thank you for being an AIM stockholder and attending our annual meeting today.

Operator

This concludes today's meeting. You may now disconnect.

Powered by